Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...

Truist Financial analyst Tobey Sommer maintained a Buy rating on Waste Management (WM – Research Report) today. The company’s shares closed ...

Truist Financial analyst Michael Roxland reiterated a Buy rating on Silgan Holdings (SLGN – Research Report) today and set a price target of ...

Analysts at Truist Financial assumed coverage on shares of Tronox (NYSE:TROX – Get Free Report) in a research note issued to ...

Fintel reports that on January 29, 2025, Truist Securities initiated coverage of Larimar Therapeutics (NasdaqGM:LRMR) with a ...

"I think the market can live with where rates are now, as long as the 10-year rate is stable," said Keith Lerner, co-chief investment officer at Truist Advisory Services, in a call following the Fed ...

As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...

Meta's earnings call is today at 5 pm ET. META stock heads into the report up 15% YTD. Analysts are focused on AI ...

Influence Media Partners has confirmed that it has secured approximately $360 million in debt financing through an inaugural ...